Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Anglia Capital is a regional investment fund and angel investor network based in the East of England, specifically serving Norfolk and Suffolk. It was established by the New Anglia Local Enterprise Partnership (LEP) to provide equity finance to high-growth, early-stage businesses. The fund frequently co-invests with private angel investors to support innovation across diverse sectors, including life sciences, agritech, and digital technology. By leveraging the research strengths of the Norwich Research Park, New Anglia Capital plays a vital role in fostering the regional biotechnology and healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Anglia Capital.